The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This randomized controlled study aims to investigate the efficiency of medical treatment
modalities in endometriosis patients. The study protocol involves two arms. (Dienogest Group
and Noretindrone Acetate Group). The patients diagnosed with endometriosis are randomized
depending on their protocol ids. The Dienogest group is prescribed 5 mg dienogest per day and
neta group is prescribed 5 mg neta per day. The pain scores will be analyzed six months and
twelve months after treatment.